Leuprolide acetate suspnsion
Products billed under this code include Eligard, Lupron Depot.
Payment limit per 7.5 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Eligard, Lupron Depot.
Payment limit per 7.5 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Eligard | Tolmar Inc. | 62935-0223-05 | 3 | $566.547 |
| Eligard | Tolmar Inc. | 62935-0227-10 | 3 | $566.547 |
| Eligard | Tolmar Inc. | 62935-0303-30 | 4 | $755.396 |
| Eligard | Tolmar Inc. | 62935-0306-40 | 4 | $755.396 |
| Eligard | Tolmar Inc. | 62935-0453-45 | 6 | $1,133.094 |
| Eligard | Tolmar Inc. | 62935-0461-50 | 6 | $1,133.094 |
| Eligard | Tolmar Inc. | 62935-0753-75 | 1 | $188.849 |
| Eligard | Tolmar Inc. | 62935-0756-80 | 1 | $188.849 |
| Lupron Depot | AbbVie Inc. | 00074-3346-03 | 3 | $566.547 |
| Lupron Depot | AbbVie Inc. | 00074-3346-55 | 3 | $566.547 |
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Lupron Depot | AbbVie Inc. | 00074-3473-03 | 6 | $1,133.094 |
| Lupron Depot | AbbVie Inc. | 00074-3473-55 | 6 | $1,133.094 |
| Lupron Depot | AbbVie Inc. | 00074-3642-03 | 1 | $188.849 |
| Lupron Depot | AbbVie Inc. | 00074-3642-55 | 1 | $188.849 |
| Lupron Depot | AbbVie Inc. | 00074-3683-03 | 4 | $755.396 |
| Lupron Depot | AbbVie Inc. | 00074-3683-55 | 4 | $755.396 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $188.849 | +$28.507 | 7.5 MG | Leuprolide acetate suspnsion | v1, posted September 17, 2026 |
| 3Q26 | $160.342 | −$15.858 | 7.5 MG | Leuprolide acetate suspnsion | v1, posted September 15, 2026 |
| 2Q26 | $176.20 | +$5.422 | 7.5 MG | Leuprolide acetate suspnsion | v1, posted September 15, 2026 |
| 1Q26 | $170.778 | −$5.669 | 7.5 MG | Leuprolide acetate suspnsion | v1, posted September 15, 2026 |
| 4Q25 | $176.447 | +$21.028 | 7.5 MG | Leuprolide acetate suspnsion | v1, posted September 8, 2026 |
| 3Q25 | $155.419 | −$16.869 | 7.5 MG | Leuprolide acetate suspnsion | v1, posted March 10, 2026 |
| 2Q25 | $172.288 | −$8.506 | 7.5 MG | Leuprolide acetate suspnsion | v1, posted March 10, 2026 |
| 1Q25 | $180.794 | +$4.284 | 7.5 MG | Leuprolide acetate suspnsion | v1, posted December 19, 2025 |
| 4Q24 | $176.51 | −$4.03 | 7.5 MG | Leuprolide acetate suspnsion | v1, posted June 11, 2025 |
| 3Q24 | $180.54 | −$5.122 | 7.5 MG | Leuprolide acetate suspnsion | v1, posted June 11, 2025 |
| 2Q24 | $185.662 | +$4.36 | 7.5 MG | Leuprolide acetate suspnsion | v1, posted March 11, 2025 |
| 1Q24 | $181.302 | +$14.617 | 7.5 MG | Leuprolide acetate suspnsion | v1, posted December 19, 2024 |
| 4Q23 | $166.685 | +$0.822 | 7.5 MG | Leuprolide acetate suspnsion | v1, posted October 10, 2024 |
| 3Q23 | $165.863 | −$6.698 | 7.5 MG | Leuprolide acetate suspnsion | v1, posted June 5, 2024 |
| 2Q23 | $172.561 | −$15.77 | 7.5 MG | Leuprolide acetate suspnsion | v1, posted February 23, 2024 |
| 1Q23 | $188.331 | +$22.256 | 7.5 MG | Leuprolide acetate suspnsion | v1, posted December 6, 2023 |
| 4Q22 | $166.075 | −$13.192 | 7.5 MG | Leuprolide acetate suspnsion | v1, posted June 22, 2023 |
| 3Q22 | $179.267 | +$10.426 | 7.5 MG | Leuprolide acetate suspnsion | v1, posted June 9, 2023 |
| 2Q22 | $168.841 | −$31.542 | 7.5 MG | Leuprolide acetate suspnsion | v1, posted December 14, 2022 |
| 1Q22 | $200.383 | +$61.293 | 7.5 MG | Leuprolide acetate suspnsion | v1, posted June 8, 2022 |
| 4Q21 | $139.09 | −$5.374 | 7.5 MG | Leuprolide acetate suspnsion | v1, posted June 2, 2022 |
| 3Q21 | $144.464 | −$59.607 | 7.5 MG | Leuprolide acetate suspnsion | v1, posted June 2, 2022 |
| 2Q21 | $204.071 | −$24.861 | 7.5 MG | Leuprolide acetate suspnsion | v1, posted March 1, 2022 |
| 1Q21 | $228.932 | – | 7.5 MG | Leuprolide acetate suspnsion | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.